Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Radicava HCPradicavahcp.com · Low evidenceRADICAVA ORS® (edaravone) is an oral suspension treatment for amyotrophic lateral sclerosis (ALS) evaluated across seven clinical trials. It is designed to slow the loss of physical function in ALS patients and is supported by a pharmacokinetic study and observational analysis.
Parse Score